Agomab Announces Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors

Agomab Therapeutics shareholders approved all resolutions at the September 11, 2026 Special and Extraordinary General Shareholders' Meeting, including the appointments of Marino Garcia and Naimish Patel, M.D. as non-executive directors. Shareholders also approved the consolidation and split adjustment of outstanding pre-IPO warrants, aligning them with the share split implemented at the company's February 2026 IPO.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.